Top Banner
Meet Molecular Architect Dr Mark Mackey Chief Scientifc Officer
39

Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Jan 26, 2015

Download

Technology

Cresset

 
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Meet Molecular Architect

Dr Mark MackeyChief Scientifc Officer

Page 2: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Outline

> Fields, Field points and the good things you can do with them

> The alignment problem

> 3D-QSAR using Fields

> Examples> SARS PLpro – small data set, known xtal structure

> NK3 – large data set, unknown xtal structure

Page 3: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

NN

Br

F FF

SH2NO

O

Field Points

Condensed representation of electrostatic, hydrophobic and shape properties (“protein’s view”)

> Molecular Field Extrema (“Field Points”)

3D Molecular Electrostatic

Potential (MEP)

Field Points= Positive = Negative= Shape= Hydrophobic

2D

Page 4: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Field Points have lots of applications

> Virtual screening

> Alignment

> Pharmacophore elucidation

> Bioisosteres

> etc

Page 5: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Field Points have lots of applications

> Virtual screening

> Alignment

> Pharmacophore elucidation

> Bioisosteres

> etc

> What about 3D QSAR?

Page 6: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

The Alignment Problem

> Historically very difficult

> Early approaches template-based> Issues with side chain orientations

> Some success with docked data sets

> Easy to fool yourself> Correlation/causation

Page 7: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Alignment issues

> Ligand-centric view vs protein-centric

Cramer, JCAMD, 2010, DOI 10.1007/s10822-010-9403-z

NN

Br

F FF

SH2NO

O

NN

Br

F FF

SH2NO

O

Page 8: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Which is better?

> “The superior statistical qualities of 3D-QSAR models based on poses that superimpose presumably critical ligand features, rather than docked conformations.” Clark R., JCAMD 2007, p587

Doweyko, J. Comp-Aided Mol. Des., 2004, p 587

Free alignment adds signal, but also noise. Worse statistics, better predictability?

Page 9: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

N-methyl acetamideImidazole

Field Alignment

H3N

N

OO

HN

O

NH

NH2H2N

O

NH

NH

HN

SOO

Page 10: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

N-methyl acetamideImidazole

Field Scoring

Cheeseright et al, J. Chem Inf. Mod., 2006, 665

To score a particular alignment, we use the field points of molecule 1 to sample the actual field of molecule 2

Page 11: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Field Scoring

N-methyl acetamideImidazole

Cheeseright et al, J. Chem Inf. Mod., 2006, 665

To score a particular alignment, we use the field points of molecule 1 to sample the actual field of molecule 2 and vice-versa

Page 12: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Field Sampling

Field-point based QSAR descriptors

Page 13: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Field Sampling

Field-point based QSAR descriptors

Page 14: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Advantages

> Many fewer sample points than grid-based methods

> E.g. Vegfr2 data set

Field Sampling Grid Sampling Filtered Grid Sampling

q2 0.62 0.42 (0.48) 0.40

Number of descriptors

466 3940 1243

Du et al., J Mol Graph Model. 27 (2009) 642-652

Page 15: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Advantages

> Many fewer sample points than grid-based methods

> Sample points physically rather than statistically chosen

> Gauge invariant

> Consistent framework for alignment and QSAR

Page 16: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Initial validation

> Tested against literature CoMFA datasets> 15 datasets with alignments available

> CoMFA average cross-validated RMSE is 0.72

> Field QSAR using CoMFA alignments is 0.74

> Simple model (volume indicator variable) is 0.83

> Data sets re-aligned using field alignment> RMSE 1.00

Page 17: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Interpretability

Electrostatic Steric Variance

Page 18: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

SARS PLpro

Page 19: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

The target

> PLpro (Papain-like protease) is a DUB target which is critical for the replication of the coronavirus responsible for SARS

> Crystal structures available with bound ligands from 2 series of compounds: structurally related (PDB entries 3E9S and 3MJ5)

> Small number of analogues – challenge to see if we can use 3D-QSAR for small data sets

Page 20: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Alignment

Page 21: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Sampling points

Page 22: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Model

3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.003.50

4.00

4.50

5.00

5.50

6.00

6.50

7.00

R² = 0.838410392100944

R² = 0.987121600034644Training SetLinear (Training Set)Test SetLinear (Test Set)

PLS Components = 5 RMSE = 0.09 RMSEP = 0.38

Page 23: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Summary

> Able to build a predictive 3D-QSAR model based on small number of analogues

> Guided (by volume of Xtal structure) alignment worked best. Free alignment was OK, but noisier.

Page 24: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

NK3 antagonists

Page 25: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

NK3 example

> GPCR target (Tachykinin receptor 3) – selectively binds Neurokinin B – target for treatment of neurological disorders such as schizophrenia

> Three series of inhibitors from Euroscreen> Scaffold-1 – 81 compounds with pIC50 (radioligand

binding) in range 4.6-8.7

> Scaffold-2 – 80 compounds with pIC50 in range 4.8-7.7

> Errors in radioligand binding data c. ± 0.4

Page 26: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

NK3 binding mode

> For a 3D method you need a 3D alignment

> FieldAlign can align to a reference

> FieldTemplater generates the reference

O

N+

NH

N

HO

O

O

OHO

H

N

N+

N

O

N

N

O

H

F

F F

F

F

O

HN N+

H

H

N N

NH

FieldTemplater

Page 27: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

NK3 binding mode prediction

> FieldTemplater> Selection of 3 highly active scaffold-1 compounds

plus 2 structurally dissimilar literature NK3 actives (Talnetant and SB-218795).

> Generated Templates filtered and candidate selected

> Conformation of most active scaff-1 structure then used as alignment target for other structures

Page 28: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

3D-QSAR details

> Alignment> Free alignment to template conformation

> Field selection> Generated Field points for both steric and electrostatic

fields, with both sets at independent locations.

> 80/20 training/test split > Most active and least active training set

> 2nd most active, 2nd least active test set

> Random distribution of remaining compounds

Page 29: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Initial models problematic

> When all else fails, talk to the chemists

> “Are you using the right tautomer?”

N N

N

N

H

N N

N

N

Page 30: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

NK3 Series 1

RMSE 0.19, RMSEpred 0.64

4.5 5 5.5 6 6.5 7 7.5 8 8.5 94.5

5

5.5

6

6.5

7

7.5

8

8.5

9

Training Set

Test Set

Page 31: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

NK3 Series 1

Electrostatics Sterics

Page 32: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Extend to scaff-2?

4 5 6 7 8 9 10 114

5

6

7

8

9

10

11

Actual vs Predicted - scaff2 compounds on scaff1 model

> Complete lack of predictivity

> Visual analysis suggests a shift in binding mode for scaff-2

> Cross-series QSAR difficult

> Requires consistent binding modes!

Page 33: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

NK1 Scaffold 2

4 4.5 5 5.5 6 6.5 7 7.5 8 8.54

4.5

5

5.5

6

6.5

7

7.5

8

8.5

TrainingTest

Activity

Pred

icted

Acti

vity

RMSEpred 0.60

Page 34: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Summary

> Able to generate models based on alignment to predicted active conformation by templating

> Independent models within each of two series show reasonable predictivity and can be used to guide further work

> Cross-series analysis suggests different binding modes for the two series

Page 35: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Molecular Architect

Page 36: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Molecular Architect

> Initially FieldAlign + QSAR

> Align your molecules

> Build models

> Test models

> Fit new compounds to models

> Interactive feedback

> Add additional alignment options

Page 37: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Molecular Architect

> One tool for molecule designers> Align

> QSAR

> Pharmacophore elucidation

> Bioisosteres

> What do I make next?

> Beta Q4 2011

Page 38: Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Acknowledgements

> Cresset> Andy Vinter

> Tim Cheeseright

> James Melville

> Chris Earnshaw

> Euroscreen> Hamid Hoveyda

> Julien Parcq